找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Current and Emerging Therapies in Pancreatic Cancer; Tanios Bekaii-Saab,Bassel El-Rayes Book 2018 Springer International Publishing AG 201

[復(fù)制鏈接]
查看: 17191|回復(fù): 68
樓主
發(fā)表于 2025-3-21 17:01:06 | 只看該作者 |倒序?yàn)g覽 |閱讀模式
書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer
編輯Tanios Bekaii-Saab,Bassel El-Rayes
視頻videohttp://file.papertrans.cn/242/241495/241495.mp4
概述Highlights the standard and emerging therapies in treating pancreatic cancer.Introduces new concepts regarding the economic effects associated with implementing new pancreatic cancer treatments.Writte
圖書(shū)封面Titlebook: Current and Emerging Therapies in Pancreatic Cancer;  Tanios Bekaii-Saab,Bassel El-Rayes Book 2018 Springer International Publishing AG 201
描述This book provides a comprehensive, state-of-the art review of current and new therapies in treating pancreatic cancer. In addition to discussing the current landscape for treating various stages of pancreatic cancer, the text highlights several standard and emerging approaches, with a particular emphasis on novel endoscopic, surgical, chemotherapeutic, radiotherapeutic, targeted, and immunotherapeutic strategies. The volume also features concepts on the potential economic effects associated with the development and implementation of new treatments in pancreatic cancer..?.Written by experts from a variety of integrative disciplines, .Current and Emerging Therapies in Pancreatic Cancer .is a valuable resource for oncologists, gastroenterologists, surgeons, and other professionals who treat and manage patients with pancreatic cancer. ?.
出版日期Book 2018
關(guān)鍵詞cystic pancreatic lesions; resectable disease; non-metastatic disease; cytotoxic therapy; JAK/Stat pathw
版次1
doihttps://doi.org/10.1007/978-3-319-58256-6
isbn_softcover978-3-319-86361-0
isbn_ebook978-3-319-58256-6
copyrightSpringer International Publishing AG 2018
The information of publication is updating

書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer影響因子(影響力)




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer影響因子(影響力)學(xué)科排名




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer網(wǎng)絡(luò)公開(kāi)度




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer網(wǎng)絡(luò)公開(kāi)度學(xué)科排名




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer被引頻次




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer被引頻次學(xué)科排名




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer年度引用




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer年度引用學(xué)科排名




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer讀者反饋




書(shū)目名稱Current and Emerging Therapies in Pancreatic Cancer讀者反饋學(xué)科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

0票 0.00%

Better Implies Difficulty

 

1票 100.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒(méi)有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-21 22:29:03 | 只看該作者
板凳
發(fā)表于 2025-3-22 01:31:31 | 只看該作者
Pathology: Premalignant and Malignant Diseases and Molecular Genetics, radiological and macroscopic findings are presented, to correlate with the detailed microscopic findings. Several illustrative gross photos, microphotographs, and tables are included. Most common hereditary syndromes and their associated risks for pancreatic cancer are listed. Molecular genetics of
地板
發(fā)表于 2025-3-22 05:39:14 | 只看該作者
Screening for Pancreatic Cancer: Who to Screen and How to Follow-Up?,ase biomarker. Therefore, screening patients at increased risk for pancreatic cancer is currently the favored strategy. This approach involves careful assessment of a patient’s family history and genetic profile as well as other nongenetic risk factors. Screening is typically offered to those with a
5#
發(fā)表于 2025-3-22 10:13:00 | 只看該作者
Staging and Prognostic Implications,e mainstay curative approach, but only one-fifth of the patients after pancreatic resection are alive at 5?years. Two different staging systems have been developed that help in determining prognosis and therapeutic strategy. TNM staging proposed by the American Joint Committee on Cancer (AJCC) divid
6#
發(fā)表于 2025-3-22 14:18:41 | 只看該作者
7#
發(fā)表于 2025-3-22 18:31:17 | 只看該作者
Imaging of Pancreatic Malignancies,y ductal system and the pancreas including mass lesions. MRI is highly accurate for identification and staging of pancreatic ductal adenocarcinoma. MRI can differentiate adenocarcinoma from other solid and cystic pancreatic lesions including neuroendocrine tumor, cystic neoplasms, and intraductal pa
8#
發(fā)表于 2025-3-22 22:34:15 | 只看該作者
Advanced Endoscopic Procedures,tent placement have a very central and important role in the diagnosis, treatment, and palliation of patients with pancreatic cancer. They are used as part of a multidisciplinary management approach which also includes both radiologic and surgical approaches to management of patients with pancreatic
9#
發(fā)表于 2025-3-23 05:19:54 | 只看該作者
10#
發(fā)表于 2025-3-23 07:29:26 | 只看該作者
The Management of Locally Advanced Nonmetastatic Pancreas Cancer,e remaining 30–40% of patients present with borderline resectable (BR) or locally advanced unresectable pancreatic cancer (LAPC). Recently endorsed by the NCCN, the Intergroup definition of BR and LAPC has been developed to promote multicenter collaboration and to standardize future clinical trials.
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-10 17:42
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
健康| 方山县| 定安县| 北川| 韶关市| 赞皇县| 永城市| 保定市| 保康县| 得荣县| 宁城县| 沙河市| 荣成市| 新竹县| 荃湾区| 韩城市| 江孜县| 桐梓县| 西安市| 南溪县| 巴东县| 兖州市| 榆中县| 晋宁县| 无棣县| 黄浦区| 手游| 德庆县| 安义县| 泸水县| 响水县| 弥勒县| 岱山县| 全州县| 蛟河市| 岑溪市| 左贡县| 布拖县| 贵定县| 丹棱县| 江孜县|